Training to Understand and Navigate Emotions and Interactions (TUNE In) for Asperger Syndrome

Phase-Based Progress Estimates
Asperger Syndrome+8 More
Training to Understand and Navigate Emotions and Interactions (TUNE In) - Behavioral
All Sexes
What conditions do you have?

Study Summary

This trial will test a new three-part treatment strategy to improve social functioning in adults with autism spectrum disorder. The treatment includes components to address social motivation, social anxiety, social cognition, social skills, and generalization of the skills to community settings.

Eligible Conditions
  • Asperger Syndrome
  • Autism Spectrum Disorders
  • Autism Spectrum Disorder
  • Pervasive Development Disorder
  • Autistic Disorder
  • Autism, Early Infantile

Treatment Effectiveness

Effectiveness Progress

1 of 3

Study Objectives

1 Primary · 0 Secondary · Reporting Duration: 1 year

1 year
reduction in Social Responsiveness Scale, Second Edition (SRS-2) - Adult (relative/other report)

Trial Safety

Trial Design

2 Treatment Groups

Nonintervention Group
1 of 2
Intervention Group
1 of 2
Active Control
Experimental Treatment

52 Total Participants · 2 Treatment Groups

Primary Treatment: Training to Understand and Navigate Emotions and Interactions (TUNE In) · No Placebo Group · N/A

Intervention Group
Experimental Group · 1 Intervention: Training to Understand and Navigate Emotions and Interactions (TUNE In) · Intervention Types: Behavioral
Nonintervention GroupNoIntervention Group · 1 Intervention: Nonintervention Group · Intervention Types:

Trial Logistics

Trial Timeline

Approximate Timeline
Screening: ~3 weeks
Treatment: Varies
Reporting: 1 year

Who is running the clinical trial?

University of PennsylvaniaLead Sponsor
1,816 Previous Clinical Trials
41,115,041 Total Patients Enrolled

Eligibility Criteria

Age 18+ · All Participants · 1 Total Inclusion Criteria

Mark “yes” if the following statements are true for you:

About The Reviewer

Michael Gill preview

Michael Gill - B. Sc.

First Published: October 2nd, 2021

Last Reviewed: October 17th, 2022

Michael Gill holds a Bachelors of Science in Integrated Science and Mathematics from McMaster University. During his degree he devoted considerable time modeling the pharmacodynamics of promising drug candidates. Since then, he has leveraged this knowledge of the investigational new drug ecosystem to help his father navigate clinical trials for multiple myeloma, an experience which prompted him to co-found Power Life Sciences: a company that helps patients access randomized controlled trials.

Who else is applying?

What state do they live in?
New York20.0%
How old are they?
< 1825.0%
18 - 6575.0%
What site did they apply to?
Perelman School of Medicine100.0%
What portion of applicants met pre-screening criteria?
Met criteria75.0%
Did not meet criteria25.0%

How responsive is this trial?

Typically responds via
Most responsive sites:
  1. Perelman School of Medicine: < 48 hours
Average response time
  • < 2 Days